ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Technology

Japan building 'world's fastest' drug research supercomputer

TOKYO -- A supercomputer being built to help drug developers analyze proteins will be the most powerful machine of its kind when it comes online later this year, according to the government-backed Riken research institute.

     Riken has already finished work on the basic design and underlying technology of the machine. It will reportedly be able to model changes in protein structures in just one day -- roughly 100 times faster than the famed K computer, Japan's mightiest, albeit less specialized, supercomputer.

     Hitachi helped develop technology for the project, which is estimated to cost around 800 million yen ($7.81 million). The machine is about the size of four bookcases and will be housed at Riken's Advanced Institute for Computational Science in Kobe.

     Prime Minister Shinzo Abe is aiming to make medicine and health care a pillar of his pro-growth policies. Riken plans to let Japanese universities and pharmaceutical companies use the new computer to give them a leg up in drug research and development.

     As advances in biotechnology become a major driving force behind the development of cancer therapies, the key to success increasingly lies in how quickly researchers can grasp the complex structures of proteins implicated in disease. Leading American and European pharmaceutical firms are already actively using supercomputers in the field.

     While no global rankings exist for machines dedicated to this kind of specialized work, Riken says the new computer will be faster than the most powerful drug research supercomputer in the U.S.

(Nikkei)

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media